AAAAAA

   
Results: 1-11 |
Results: 11

Authors: GOXE B LATOUR N BARTHOLEYNS J ROMETLEMONNE JL CHOKRI M
Citation: B. Goxe et al., MONOCYTE-DERIVED DENDRITIC CELLS - DEVELOPMENT OF A CELLULAR PROCESSOR FOR CLINICAL-APPLICATIONS, Research in immunology (Paris), 149(7-8), 1998, pp. 643-646

Authors: BARTHOLEYNS J ROMETLEMONNE JL CHOKRI M BUYSE M VELU T BRUYNS C VANDEWINKEL JJ HEENEY J KOOPMAN G MALMSTEN M DEGROOTE D MONSIGNY M MIDOUX P ALARCON B
Citation: J. Bartholeyns et al., CELLULAR VACCINES, Research in immunology (Paris), 149(7-8), 1998, pp. 647-649

Authors: LEWALLE P ROUAS R LEHMAN F LATOUR N ROMETLEMONNE JL CHOKRI M MARTIAT P
Citation: P. Lewalle et al., GENERATION OF DENDRITIC CELLS IN BAGS IMPACTS ON THEIR PHENOTYPE BUT NOT ON THEIR CAPACITY OF INDUCING IMMUNE SPECIFIC REACTION, Journal of leukocyte biology, 1998, pp. 16-16

Authors: ROUAS R LEWALLE P LEHMAN F LATOUR N ROMETLEMONNE JL CHOKRI M MARTIAT P
Citation: R. Rouas et al., CONGELATION-DECONGELATION OF PULSED DENDRITIC CELLS DOES NOT INFLUENCE THEIR ABILITY TO INDUCE ANTIGEN-SPECIFIC IMMUNE-RESPONSES, Journal of leukocyte biology, 1998, pp. 18-18

Authors: ROUARD H BOUQUET C LEON A ROMETLEMONNE JL FARCET JP HADDADA H DELFAULARUE MH
Citation: H. Rouard et al., ADENOVIRUS-MEDIATED GENE-TRANSFER IN HUMAN MONOCYTE-DERIVED DENDRITICCELLS, Journal of leukocyte biology, 1998, pp. 24-24

Authors: ROMETLEMONNE JL BARTHOLEYNS J CHOKRI M
Citation: Jl. Rometlemonne et al., ADOPTIVE THERAPY BY MONOCYTE-DERIVED MACROPHAGES PROCESSING EXOGENOUSANTIGENS, Journal of leukocyte biology, 1996, pp. 226-226

Authors: CHOKRI M LATOUR N MARTINACHE C BERNARD J BARTHOLEYNS J ROMETLEMONNE JL LOPEZ M
Citation: M. Chokri et al., EFFECT OF IN-VIVO PRIMING OF HUMAN MONOCYTES BY IFN-GAMMA ON THEIR EX-VIVO DIFFERENTIATION INTO MACROPHAGES AND CYTOKINE RELEASE, Journal of leukocyte biology, 1996, pp. 227-227

Authors: BARTOLEYNS J ROMETLEMONNE JL CHOKRI M LOPEZ M
Citation: J. Bartoleyns et al., IMMUNE THERAPY WITH MACROPHAGES - PRESENT STATUS AND CRITICAL REQUIREMENTS FOR IMPLEMENTATION, Immunobiology, 195(4-5), 1996, pp. 550-562

Authors: MARANINCHI D BARBET J BATTAIS J EMILIE D GOEHRS JM GUINOT P MANNONI P MEYER P ROMETLEMONNE JL TROUVIN JH CALVO F GALANAUD P GOUYETTE A JULOU CL MARCEL T MOREL A QUENTINMILLET MJ SCHATZ C WIJDENES J
Citation: D. Maraninchi et al., WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN, Therapie, 51(4), 1996, pp. 431-433

Authors: MICHON J MOUTEL S BARBET J ROMETLEMONNE JL DEO YM FRIDMAN WH TEILLAUD JL
Citation: J. Michon et al., IN-VITRO KILLING OF NEUROBLASTOMA-CELLS BY NEUTROPHILS DERIVED FROM GRANULOCYTE-COLONY-STIMULATING FACTOR-TREATED CANCER-PATIENTS USING AN ANTI-DISIALOGANGLIOSIDE ANTI-FC-GAMMA-RI BISPECIFIC ANTIBODY, Blood, 86(3), 1995, pp. 1124-1130

Authors: MABONDZO A BOUSSIN F RAOUL H LENAOUR R GRAS G VASLIN B BARTHOLEYNS J ROMETLEMONNE JL DORMONT D
Citation: A. Mabondzo et al., ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY AND NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HIGH-AFFINITY CROSS-LINKING OF GP41 TO HUMAN MACROPHAGE FC IGG RECEPTOR USING BISPECIFIC ANTIBODY, Journal of General Virology, 75, 1994, pp. 1451-1456
Risultati: 1-11 |